Long-Term Efficacy of Methylphenidate Immediate-Release for the Treatment of Childhood ADHD

J Atten Disord. 2017 Jan;21(1):3-13. doi: 10.1177/1087054714559643. Epub 2016 Jul 28.

Abstract

Objective: To evaluate the long-term effects of methylphenidate imediate-release (MPH-IR), and to confirm the efficacy established in previous meta-analyses of short-term studies.

Method: Published and unpublished studies in which participants were treated with MPH-IR for 12 weeks or more were searched. Pooled effect sizes from these studies were computed with the DerSimonian and Laird random-effect model. Meta-regression analysis was conducted to estimate covariates associated with treatment effects.

Results: Seven studies were included. Pooled parents ratings for inattention and hyperactivity/impulsivity resulted in standardized mean difference (SMD) = 0.96 (95% confidence interval [CI] = [0.60, 1.32]) and SMD = 1.12 (95% CI = [0.85, 1.39]), respectively; pooled teachers ratings showed SMD = 0.98 (95% CI = [0.09, 1.86]) for inattention and SMD = 1.25 (95% CI = [0.7, 1.81]) for hyperactivity/impulsivity. No evidence of association of any covariates with treatment effect was detected in the meta-regression.

Conclusion: MPH-IR is efficacious for childhood ADHD for periods longer than 12 weeks.

Keywords: ADHD; meta-analysis; methylphenidate; review.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Central Nervous System Stimulants / administration & dosage*
  • Child
  • Drug Administration Schedule
  • Female
  • Humans
  • Impulsive Behavior / drug effects
  • Methylphenidate / administration & dosage*
  • Randomized Controlled Trials as Topic
  • Regression Analysis
  • Treatment Outcome

Substances

  • Central Nervous System Stimulants
  • Methylphenidate